Access to mental healthcare
Antidepressant use in Europe continues to break records
Doctors continue prescribing anti-anxiety medications such as lorazepam or diazepam for long periods despite the risk of addictions. Meanwhile, under-investment in psychological care is making things worse.
The slow, uneven wane of the institutional psychiatry model in Europe
In the European Union, thousands of people with serious mental disorders live isolated and secluded from society, without receiving all the care they need. At least 150 million euros of EU funds, intended to improve their situation, have been used for other purposes.
Pay up or put it off: how Europe treats depression and anxiety
In many European countries, the availability of psychological treatment in the public healthcare system is inadequate or even non-existent. Barriers such as long waiting lists, co-payments and inadequate resources push people with anxiety or depression – those who can afford it – to the private system.
COVID-19 has paralysed mental health care in Europe
Mental health resources in the European Union were scarce even before the pandemic. COVID-19 has caused a tsunami in mental health, and access to care is more difficult today. About 75 percent of psychiatry services in the EU have been taking place via telemedicine, but this is not a viable option for all patients.
